House of Commons
As this motion is using historical data, we may not have the record of the original ordering, in which case signatories are listed alphabetically.
NEUROBLASTOMA TREATMENT
EDM #665
Tabled 04 November 2013
2013-14 Session
That this House recognises that neuroblastoma affects around 100 children a year in the UK; further recognises that children with this type of cancer have an 80 to 95 per cent chance of relapsing at any time until they reach the age of 20; understands that the best chance of survival is by using a new treatment called Radioimmunosorbent Test (RIST); acknowledges that those suffering from the disease have to travel abroad for RIST treatment because none is available in the UK; notes that the cost of RIST treatment can be as high as £300,000; and calls on the Government to consider ways in which RIST treatment can be made available in the UK.

Signatures (30)

The first 6 Members who have signed to support the motion are the sponsors. The primary sponsor is generally the person who tabled the motion and has responsibility for it. The date shown is when the Member signed the motion.
In addition to the sponsors, the following Members have signed to support the motion.
There are no withdrawn signatures for this Motion